Enzo Biochem Reports Third Quarter Fiscal 2024 Results and Provides Business Update

FARMINGDALE, N.Y., June 13, 2024 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) ("Enzo" or the "Company") today announced financial results for the fiscal third quarter ended April 30, 2024. The Company's Life Science division's third-quarter revenue of $8.0 million improved year-over-year by 7%, marking four consecutive quarters of revenue growth compared to the prior year quarterly periods. Revenue for the nine months ended April 30, 2024 of$ 24.4 million improved 10% compared to the same year-to-date ...